S&P Global
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
@yenoms You think $BX or anyone can take this one down?
$DIS making a comeback attempt from "fallen angel" status...
@challeyok You can go look at the GFC performance for $PSA The coverage ratio is 6.1x, will need NOI/EBITDA to fall over 80% before they have distribution issues
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term…
Deckers Outdoor trades at 12 times trailing earnings as HOKA and UGG grow, while buybacks could retire 8% of shares and support EPS.
Steve Eisman, Dan Ives and Gil Luria assess how the midterms could reshape AI data-center spending, Google search growth, and competition…
Reddit's search-traffic selloff overlooks that logged-in app users generate more than 80% of monetization, supporting a $130 one-year…
FactSet CEO Sanoke Viswanathan discusses using the firm’s client relationships and data platform to deploy AI across finance.
Accenture reported 6.5% FY26 revenue growth and $11.6 billion in free cash flow, while fixed-price contracts above 65% of bookings retain…
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
Ondas reported $167.5 million in Q3 revenue but spent $562 million of cash, halved gross margin and fell below its $6 stop level.
Offshore Radar maps 160-plus listed offshore rigs, contracts, day rates and uncontracted capacity through 2029.
Travere Therapeutics' FILSPARI has two FDA approvals and is driving revenue growth, while TVTX shares have nearly tripled since August 2025.
MOH · long Molina Healthcare is presented as a long investment in the widely disliked U.S. health-insurance industry.
Jackson Financial administers $287 billion in retirement accounts while a report says its captive, hedge-loss installment plan and…
Copart's U.S. insurance volumes fell 7.5% in 4Q26, largely from one customer loss, while international insurance units rose 11.2% and…
Viridian Therapeutics is building a shared commercial platform for Lumvoa and investigational elegrobart in thyroid eye disease, with…
Figure Technology's HELOC platform grew Q2 2026 revenue 113% with a 54.6% adjusted EBITDA margin, while shares trade 57% below January's…
Vistra’s Q2 2026 results reinforce its PJM and ERCOT generation advantage as AI data-center demand tightens power supply, supported by…
Copart’s 4Q26 revenue grew 2.4% as U.S. insurance volumes fell 7.5%, while a customer loss and higher yard costs pressured profits despite…
Nu Bank’s U.S. launch pairs 4.5% APY and 2% cashback with fee-free USDC remittances, pressuring SoFi, Capital One and cross-border transfer…
Kodiak Sciences expects Phase 3 DAYBREAK results for Zenkuda and KSI-501 in wet AMD, with durability and vision outcomes key beyond…
QXO applies Brad Jacobs’s consolidation playbook to fragmented building materials, anchored by its TopBuild acquisition and a strategy of…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.